Diabetic macular edema (DME) is a leading cause of vision impairment among working-age adults, and the public health burden it imposes will only increase as the global prevalence of diabetes continues to rise.1 To improve future outcomes for patients, caregivers, and health care systems, it is important to understand the current state of DME management in clinical practice. The American Academy of Ophthalmology Intelligent Research in Sight (IRIS®) Registry, containing data from the electronic health records of participating ophthalmologists, optometrists, and other eye care providers, was developed to improve the quality of ophthalmic care in the United States.
No takes yet. Share an insight, caveat, or question.
Cantrell et al. (2019) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: